Propylthiouracil
 
PTU is a drug used to treat hyperthyroidism, including Graves’s disease which is a common form of hyperthyroidism characterized by goiter and often a slight protrusion of the eyeballs, by decreasing the amount of thyroid hormones produced by the thyroid gland. The most notable side effect of PTU is the risk of agranulocytosis. This is an acute febrile condition marked by severe depression of the agranulocyte-producing bone marrow and by prostration, chills, swollen neck, and sore throat sometimes with local ulceration and believed to be basically a response to the side effects of certain drug of the coal-tar series. Contact the lawyers at the Singleton Law Firm today if you have suffered any of the following side effects.

Other side effects may include the following: skin rash, itching, abnormal hair loss, upset stomach, vomiting, loss of taste, abnormal sensations (tingling, prickling, burning, tightness, and pulling), swelling, joint and muscle pain, drowsiness, dizziness, decreased white blood cells, abnormal hair loss, and decreased platelets. 

Serious side effects may occur, including the following: sore throat, fever, headache, chills, unusual bleeding or bruising, right-side abdominal pain with decreased appetite, yellowing of the skin or eyes, and skin eruptions.

The drug is generally well-tolerated with its side effects occurring in 1 out of every 100 patients, but it is classified as a Drug Class D in pregnancy. This means that there is positive evidence of human fetal risk. Maternal benefit may outweigh fetal risk in life-threatening situations. The primary effect on the fetus is the production of a mild hypothyroidism when the drug is used close to term.

The Singleton Law Firm is ready to assist you if you have suffered injury from the use of Propylthiouracil. Contact our attorneys for a free case evaluation.


Return to the Defective Drugs Listing >
Home | About the Firm | Attorneys | Management & Staff | In the News | Practice Areas | Injury Alerts | FDA Info | CPSC
EPA Warnings | Press & Articles | Online Resources | Contact Us